BMD and fracture risk in CKD: Where should we go from here?

Clinical Journal of the American Society of Nephrology

Volumn 7, Issue 7, 2012, Pages 1058-1060

  Nickolas, Thomas L ^a  

^a Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE DENSITY; BONE DISEASE; CHRONIC KIDNEY DISEASE; DUAL ENERGY X RAY ABSORPTIOMETRY; EDITORIAL; FEMUR NECK FRACTURE; FRACTURE; FRAGILITY FRACTURE; GLOMERULUS FILTRATION RATE; HIP FRACTURE; HUMAN; HYPERPARATHYROIDISM; RISK ASSESSMENT; SPINE FRACTURE;

BODY MASS INDEX; FRACTURES, BONE; HISTORY, 20TH CENTURY; HUMANS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84863741241     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.05320512     Document Type: Editorial

References (27)

1. Nickolas TL, Cremers S, Zhang A, Thomas V, Stein E, Cohen A, Chauncey R, Nikkel L, Yin MT, Liu XS, Boutroy S, Staron RB, Leonard MB, McMahon DJ, Dworakowski E, Shane E: Discriminants of prevalent fractures in chronic kidney disease. J Am Soc Nephrol 22: 1560-1572, 2011
2. Nickolas TL, Stein E, Cohen A, Thomas V, Staron RB, McMahon DJ, LeonardMB, Shane E: Bonemass andmicroarchitecture inCKD patients with fracture. J Am Soc Nephrol 21: 1371-1380, 2010
3. Jamal SA, Cheung AM, West SL, Lok CE: Bonemineral density by DXA and HR pQCT can discriminate fracture status in men and women with stages 3 to 5 chronic kidney disease [published ahead of print on Feburary 2, 2012]. Osteoporos Int doi:10.1007/ s00198-012-1908-y
4. Jamal SA, Hayden JA, Beyene J: Low bone mineral density and fractures in long-term hemodialysis patients: A meta-analysis. Am J Kidney Dis 49: 674-681, 2007
5. Jamal SA, Gilbert J, Gordon C, Bauer DC: Cortical pQCT measures are associated with fractures in dialysis patients. J Bone Miner Res 21: 543-548, 2006
6. Jamal SA, Chase C, Goh YI, Richardson R, Hawker GA: Bone density and heel ultrasound testing do not identify patients with dialysis-dependent renal failure who have had fractures. Am J Kidney Dis 39: 843-849, 2002
7. Yamaguchi T, Kanno E, Tsubota J, Shiomi T, Nakai M, Hattori S: Retrospective study on the usefulness of radius and lumbar bone density in the separation of hemodialysis patients with fractures from those without fractures. Bone 19: 549-555, 1996
8. Piraino B, Chen T, Cooperstein L, Segre G, Puschett J: Fractures and vertebral bone mineral density in patients with renal osteodystrophy. Clin Nephrol 30: 57-62, 1988
9. McCarthy JT, Rule AD, Achenbach SJ, Bergstralh EJ, Khosla S, Melton LJ 3rd: Use of renal function measurements for assessing fracture risk in postmenopausal women. Mayo Clin Proc 83: 1231-1239, 2008
10. Jassal SK, von Muhlen D, Barrett-Connor E: Measures of renal function, BMD, bone loss, and osteoporotic fracture in older adults: The Rancho Bernardo study. J Bone Miner Res 22: 203-210, 2007
11. Iimori S, Mori Y, AkitaW, Kuyama T, Takada S, Asai T, Kuwahara M, Sasaki S, Tsukamoto Y: Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients-a single-center cohort study. Nephrol Dial Transplant 27: 345-351, 2012
12. Ureña P, Bernard-Poenaru O, Ostertag A, Baudoin C, Cohen-Solal M, Cantor T, de Vernejoul MC: Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients. Nephrol Dial Transplant 18: 2325-2331, 2003
13. Rix M, Andreassen H, Eskildsen P, Langdahl B, Olgaard K: Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. Kidney Int 56: 1084-1093, 1999
14. KDIGO: Chapter 3.1: Diagnosis of CKD-MBD: Biochemical abnormalities. Kidney Int 76[Suppl 113]: S22-S49, 2009
15. Abbott KC, Oglesby RJ, Hypolite IO, Kirk AD, Ko CW, Welch PG, Agodoa LY, Duncan WE: Hospitalizations for fractures after renal transplantation in the United States. Ann Epidemiol 11: 450-457, 2001
16. West SL, Lok CE, Jamal SA: Fracture risk assessment in chronic kidney disease, prospective testing under real world environments (FRACTURE): A prospective study. BMC Nephrol 11: 17, 2010
17. Yenchek RH, Ix JH, Shlipack MG, Bauer DC, Rianon NJ, Kritchevsky SB, Harris TB, Newman AB, Cauley JA, Fried LF, for the Health, Aging, and Body Composition Study: Bone mineral density and fracture risk in older individuals with CKD. Clin J Am Soc Nephrol 7: 1130-1136, 2012
18. Melton LJ 3rd, Christen D, Riggs BL, Achenbach SJ, Muller R, van Lenthe GH, Amin S, Atkinson EJ, Khosla S: Assessing forearm fracture risk in postmenopausal women. Osteoporos Int 21: 1161-1169, 2010
19. Vico L, Zouch M, Amirouche A, Frére D, Laroche N, Koller B, Laib A, Thomas T, Alexandre C:High-resolution pQCTanalysis at the distal radius and tibia discriminates patients with recent wrist and femoral neck fractures. J Bone Miner Res 23: 1741-1750, 2008
20. Boutroy S, Bouxsein ML, Munoz F, Delmas PD: In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography. J Clin Endocrinol Metab 90: 6508-6515, 2005
21. Dukas LC, Schacht E, Mazor Z, Stähelin HB: A new significant and independent risk factor for falls in elderly men andwomen: A low creatinine clearance of less than 65 ml/min. Osteoporos Int 16: 332-338, 2005
22. West SL, Jamal SA, Lok CE: Tests of neuromuscular function are associatedwith fractures in patients with chronic kidney disease. Nephrol Dial Transplant 27: 2384-2388, 2011
23. Miller PD, Roux C, Boonen S, Barton IP, Dunlap LE, Burgio DE: Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials. J Bone Miner Res 20: 2105-2115, 2005
24. Miller PD, Schwartz EN, Chen P, Misurski DA, Krege JH: Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment. Osteoporos Int 18: 59-68, 2007
25. Miller PD: The kidney and bisphosphonates. Bone 49: 77-81, 2011
26. Jamal SA, Bauer DC, Ensrud KE, Cauley JA, Hochberg M, Ishani A, Cummings SR: Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial. J Bone Miner Res 22: 503-508, 2007
27. Jamal SA, Ljunggren O, Stehman-Breen C, Cummings SR, McClung MR, Goemaere S, Ebeling PR, Franek E, Yang YC, Egbuna OI, Boonen S, Miller PD: Effects of denosumab on fracture and bone mineral density by level of kidney function. J Bone Miner Res 26: 1829-1835, 2011